302 related articles for article (PubMed ID: 20534128)
1. CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures.
Oermann E; Collins BT; Erickson KT; Yu X; Lei S; Suy S; Hanscom HN; Kim J; Park HU; Eldabh A; Kalhorn C; McGrail K; Subramaniam D; Jean WC; Collins SP
J Hematol Oncol; 2010 Jun; 3():22. PubMed ID: 20534128
[TBL] [Abstract][Full Text] [Related]
2. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
3. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes Following Conventionally Fractionated Stereotactic Boost for High-Grade Gliomas in Close Proximity to Critical Organs at Risk.
Repka MC; Lei S; Campbell L; Suy S; Voyadzis JM; Kalhorn C; McGrail K; Jean W; Subramaniam DS; Lischalk JW; Collins SP; Collins BT
Front Oncol; 2018; 8():373. PubMed ID: 30254985
[No Abstract] [Full Text] [Related]
5. Low-grade gliomas.
Stieber VW
Curr Treat Options Oncol; 2001 Dec; 2(6):495-506. PubMed ID: 12057095
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
[TBL] [Abstract][Full Text] [Related]
7. Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery.
Choi SW; Cho KR; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI
J Neurooncol; 2019 Dec; 145(3):571-579. PubMed ID: 31705245
[TBL] [Abstract][Full Text] [Related]
8. Clinical Efficacy of CyberKnife Radiosurgery for Adult Brainstem Glioma: 10 Years Experience at Tianjin CyberKnife Center and Review of the Literature.
Zhang J; Liu Q; Yuan Z; Zhao L; Wang X; Wang P
Front Oncol; 2019; 9():257. PubMed ID: 31032223
[No Abstract] [Full Text] [Related]
9. Multifocal high-grade glioma radiotherapy safety and efficacy.
Fleischmann DF; Schön R; Corradini S; Bodensohn R; Hadi I; Hofmaier J; Forbrig R; Thon N; Dorostkar M; Belka C; Niyazi M
Radiat Oncol; 2021 Aug; 16(1):165. PubMed ID: 34454558
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas.
Den RB; Kamrava M; Sheng Z; Werner-Wasik M; Dougherty E; Marinucchi M; Lawrence YR; Hegarty S; Hyslop T; Andrews DW; Glass J; Friedman DP; Green MR; Camphausen K; Dicker AP
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):321-8. PubMed ID: 22687197
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
12. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
13. Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma.
Bergman D; Modh A; Schultz L; Snyder J; Mikkelsen T; Shah M; Ryu S; Siddiqui MS; Walbert T
J Neurooncol; 2020 Jun; 148(2):353-361. PubMed ID: 32444980
[TBL] [Abstract][Full Text] [Related]
14. High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas.
Watkins JM; Marshall DT; Patel S; Giglio P; Herrin AE; Garrett-Mayer E; Jenrette JM
J Neurooncol; 2009 Jul; 93(3):343-8. PubMed ID: 19142584
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience.
Guan Y; Xiong J; Pan M; Shi W; Li J; Zhu H; Gong X; Li C; Mei G; Liu X; Pan L; Dai J; Wang Y; Wang E; Wang X
BMC Cancer; 2021 Feb; 21(1):123. PubMed ID: 33546642
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma.
Landy H; Markoe A; Potter P; Lasalle G; Marini A; Savaraj N; Reis I; Heros D; Wangpaichitr M; Feun L
J Neurooncol; 2004; 67(1-2):215-20. PubMed ID: 15072470
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
19. CyberKnife stereotactic radiotherapy for patients with malignant glioma.
Yoshikawa K; Saito K; Kajiwara K; Nomura S; Ishihara H; Suzuki M
Minim Invasive Neurosurg; 2006 Apr; 49(2):110-5. PubMed ID: 16708341
[TBL] [Abstract][Full Text] [Related]
20. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
